A B S T R A C T Maximum specific 5a-dihydrotestosterone (DHT) binding activity (B.ax) has been measured in intact confluent monolayers representing fibroblast strains derived from nongenital and genital (labium majus) skin of normal individuals and of 11 patients fulfilling the clinicogenetic criteria of complete testicular feminization (TF). Nine labium majus strains from adult females had a mean Bmas value three times greater than that of seven nongenital strains from adult females (33 vs. 11 fmol/mg cell protein). The Bmax results for 13 adult nongenital strains varied from 5.6 to 23.3 fmol/ mg protein; the values for males and females had very similar means and ranges. The variation could not be correlated with the chronologic age of adult skin explant donors or with the in vitro age (mean population doubling level) of the cultures assayed. The Bmax activities of three nongenital strains from normal infants (two male, one female) did not exceed 5 fmol/mg protein. Seven of eight nongenital TF strains had Bmax values below 2 fmol/mg protein; the value for the eighth coincided with the lower limit of normal adults. 
INTRODUCTION
Target cell unresponsiveness to androgen has been identified as the cellular fault in three types of human male sexual maldevelopment caused by mendelian gene mutation. The prototype disorder is X-linked (1) complete testicular feminization (TF) ' in which there is neither normal male differentiation of the Wolffian ducts, urogenital sinus or genital tubercle, folds and swellings prenatally, nor genital or somatic virilization at puberty. These patients are resistant to testosterone and its immediate derivative, 5a-dihydrotestosterone (DHT, 5a-androstan-17P-ol-3-one) (2) . Familial incomplete male pseudohermaphroditism (FIMP), type 1 is like TF in pattern of genetic transmission, the universality of target organs affected, and presumably in concordant resistance to testosterone and DHT, but its defect is incomplete in severity and variable in expression (3) . All patients with TF and most with FIMP, type 1 have female breast development because of elevated plasma estradiol levels secondary to defective 'Abbreviations used in this paper: Bma., maximum binding capacity; DHT, 5a-androstan-17fi-ol-3-one; FIMP, familial incomplete male pseudohermaphroditism; Kd, apparent dissociation constant; MP, male pseudohermaphroditism; 5a-reductase, A'-3-ketosteroid-5a-oxidoreductase; TF, testicular feminization. * The final letter of the cell strain codes denotes the anatomic source of the skin explant from which the strain was developed: A abdominal (suprapubic); D, deltoid area of the arm; L, labium majus; N, nongenital (source unknown); X, axilla.
feedback regulation of luteinizing hormone secretion at the pituitary-hypothalamic level (3). FIMP, type 2 resembles the most severe expression of the type 1 disorder from the external genital viewpoint, but differs from the other two in having an autosomal recessive etiology, normal Wolffian duct differentiation, no gynecomastia, and prominent somatic and genital virilization at puberty (4, 5) . The phenotype of this disorder is explainable by reduced conversion of testosterone to DHT, due to deficient A'-3-ketosteroid-5a-oxidoreductase (5a-reductase) activity, in DHT-dependent targets such as the urogeni,tal sinus and external genital primordia before birth, and the prostate and facial hair follicles at puberty (5).
Fibroblasts cultured from normal human skin metabolise testosterone to DHT as well as other 5a-reduced products (6, 7) and they synthesize a specific receptor protein that binds DHT in the cy.toplasm and translocates it into the nucleus (8) . Skin fibroblasts cultured from genital skin (prepuce, labium majus, and scrotum) perform both functions to a greater extent than do those from various nongenital skin sites (7) (8) (9) (10) . The preservation of such differentiative properties in serially subcultured skin fibroblasts predicts that these cells will express the mutations responsible for the three known types of androgen-unresponsive male sexual maldevelopment. The prediction has been fulfilled. Thus, preputial skin fibroblasts of patients with type 2 FIMP have deficient 5a-reductase activity (7) , and skin fibroblasts (both genital and nongenital) from patients with TF lack or have very low levels of the specific receptor protein (s) responsible for binding DHT (10, 11) .
The purpose of this study was to measure DHT binding activity in genital and nongenital skin fibroblast cell strains derived from a group of 11 patients referred with the diagnosis of TF. It is important to note that a majority of the cell strains studied represent patients whose testes were removed either before the advent of accurate radioreceptor or radioimmunoassays for the sex hormones and gonadotropins, or, before experience with these assays for accura.te differential diagnosis of male pseudohermaphroditism (MP) was widely disseminated. Furthermore, none of the cell strains belongs to a patient whose anabolic unresponsiveness to androgen has been assessed. Nevertheless, all of the patients whose strains were chosen for study were de- termination (28) and scintillation counting (29) . RESULTS
The mean specific dihydrotestosterone Bmax for the individual skin fibroblast cell strains of various classes are shown in Fig. 2 values for the nongenital strains fell below the lower limit of the controls. Unfortunately, we do not have nongenital strains from the two patients whose labial strain results (SFL and RDL) were close to the lower limit of the controls.
DISCUSSION
As a group serially subcultured adult labial skin fibroblast strains have significantly more specific DHT binding than strains derived from nongenital skin of both sexes varying in age from 1 to 60 yr. Six of nine labial strains had Bnax values exceeding 25 fmol/mg cell protein, whereas none of the nongenital strains did, including seven from adult females. Keenan et al. (8) have previously alluded to the tendency of foreskin strains to have more DHT binding than nongenital strains.
The difference between genital and nongenital strains in respect to DHT binding recalls the fact that genital strains metabolise testosterone more rapidly than those from nongenital skin (7, 9) . The variability among strains within *each class in respect to DHT binding is surpassed by their variability in rates of testosterone metabolism (7) and amounts of 5a-reductase activity (32) . The origin of this variability is not known, but one clue is derived from studies indicating that singlecell clones isolated from one strain can differ in their patterns of testosterone metabolism (33) and in their amounts of DHT binding (1).
The lower limit of DHT binding in our control nongenital strains is so close to the lowest detectable level that the diagnosis of even a severe DHT binding deficiency would carry a significant risk of error. In contrast, the spread between the lower limit of our control labial strains and the lowest detectable level is large enough to permit not only a confident diagnosis of complete DHT binding deficiency but also the strong suspicion of intermediate degrees of such a deficiency.
A decisive precedent for this situation is found in the use of cultured skin fibroblasts to diagnose 5a-reductase deficiency in patients with type 2 FIMP (4). Here, the enzyme activity in nongenital fibroblasts from the patients falls within the range of normal nongenital fibroblasts so that the phenotype can be recognized only in genital (foreskin) fibroblasts (7) .
It is clear from the present study that two of the labial strains derived from patients with the phenotype of complete TF have a lesser degree of DHT binding deficiency than the three others (column 4, Fig. 2 ). The existence of such heterogeneity has been affirmed by Amrhein et al. (34) , who have recently discovered a family with complete TF whose cultured skin fibroblasts have quantitatively normal DHT binding. Of the eight nongenital TF strains that we have studied, the one (HCD, column 2, Fig. 2 ) with normal DHT binding may represent a patient of the latter type.
If those patients who have the typical phenotype of TF despite quantitatively normal fibroblast DHT binding can be shown to have cytoplasmic DHT receptors that are qualitatively normal, then a defect in target cell responsiveness to DHT centripetal to the step of cytoplasmic binding is possible. It is important to realize, however, that defective nuclear localization or chromatin binding may be secondary to selective dysfunction of cytoplasmic receptors that retain a normal ability to bind DHT (35) .
Measurement of specific DHT binding in cultured genital skin fibroblasts should be an early step in the diagnosis and management of individuals or families with MP. The result can indicate the priorities that should be attached to standard tests for evaluating the testis-pituitary-hypothalamic axis, may influence gender assignment when anatomic considerations permit a choice, and will inevitably accelerate the accumulation of knowledge on the heterogeneity of those forms of male sexual maldevelopment that are due to deficits or defects in the molecular apparatus that underlies normal androgen responsiveness.
